Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ATEA-PHARMACEUTICALS-INC-114338425/news/Atea-Pharmaceuticals-Announces-First-Patient-Dosed-in-Phase-2-Study-for-Treatment-of-Hepatitis-C-wit-44119055/?utm_source=whatsapp&utm_medium=social&utm_campaign=share